Nurse Practitioner- Medical Cannabis
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainAnxietyMental HealthSafetyDosingIndustryResearch Dr. Caplan’s Take I appreciate the focus on patient-centered…
The Power of Patient Stories: How Lived Experience is Shifting Medical Cannabis Stigma
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. Mental HealthResearchPolicyAnxietySafetyIndustryPain Why This Matters Clinicians treating psychiatric patients may…
Understanding Modern Cannabis Extraction Methods and Product Quality
✦ New CED Clinical Relevance #52 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustrySafetyTHCCBDDosingHemp Why This Matters Clinicians need to understand modern extraction methods because…
Nebraska hemp industry faces uncertain future
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempTHCIndustrySafetyCBDDosing Why This Matters Clinicians need to understand that regulatory uncertainty in…
Michigan universities can’t study dispensary pot on campus. MSU went mobile
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchPolicySafetyMental HealthNeurologyAnxietyIndustry Why This Matters Michigan’s restriction on campus…
Summer Bud Guide
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. IndustryTHCCBDSafetyDosingResearchPolicy Why This Matters Clinicians should understand that patients increasingly make…
PleoPharma Announces 1st Patient Dosed in Phase 3 Clinical Trial for Cannabis Use Disorder
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthSafetyCBDDosingHempIndustry Why This Matters This Phase 3 trial represents progress toward a…
Guest columnist: Washington should ensure stable hemp market | State-Journal
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyHempCBDIndustrySafetyResearchDosing Why This Matters Clinicians prescribing or recommending hemp-derived…
Michigan universities can’t study dispensary pot on campus. MSU went mobile
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyIndustryNeurologyMental HealthAnxiety Why This Matters Restrictions on campus-based cannabis research…
DEA Judge Issues Order Laying Out Process For Marijuana Rescheduling Hearing Starting …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PolicyResearchSafetyTHCHempIndustryMental Health Why This Matters Clinicians need to understand this regulatory…
